Mahkam Zanganeh - Nov 13, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Nov 13, 2023
Transactions value $
$162,801
Form type
4
Date filed
11/15/2023, 05:37 PM
Previous filing
Oct 16, 2023
Next filing
Dec 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Options Exercise $42.8K +20K +3.78% $2.14 549K Nov 13, 2023 Direct
transaction PLSE Common Stock Options Exercise $120K +56.1K +10.22% $2.14 605K Nov 13, 2023 Direct
holding PLSE Common Stock 27K Nov 13, 2023 Immediate family member 1
holding PLSE Common Stock 14K Nov 13, 2023 Immediate family member 2
holding PLSE Common Stock 107K Nov 13, 2023 Immediate family member 3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Options Exercise $0 -20K -100% $0.00* 0 Nov 13, 2023 Common Stock 20K $2.14 Direct F1
transaction PLSE Stock Option (right to buy) Options Exercise $0 -56.1K -100% $0.00* 0 Nov 13, 2023 Common Stock 56.1K $2.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a monthly basis following the Company's 2022 Annual Stockholder Meeting.
F2 Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a quartetrly basis following the Company's 2022 Annual Stockholder Meeting.